Dong Zhiyu, Li Ouyang, Li Yanglei, Xiao Zili, Li Feng, Xu Shuchang, Ji Danian
Department of Gastrointestinal Endoscopy, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Department of Gastroenterology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Surg Endosc. 2025 May;39(5):3354-3363. doi: 10.1007/s00464-025-11732-2. Epub 2025 Apr 17.
Endoscopists' adenoma detection rate (ADR) may change over time and dynamic ADR has been identified as a predictor for post-screening colorectal cancer. However, whether low-risk findings removed by an endoscopist with a lower dynamic ADR benefit from a shorter duration of follow-up requires further research.
We conducted a two-center retrospective study of individuals who had low-risk findings removed and underwent subsequent surveillance colonoscopy. Endoscopists' dynamic ADR was the ADR of the previous 100 screening colonoscopies performed by the same endoscopist. A Cox-regression model and Kaplan-Meier survival analysis were used to explore the relationship between dynamic ADR and metachronous advanced colorectal neoplasia (ACRN).
Totally, 3471 individuals who had low-risk findings removed in baseline colonoscopy were included in analysis. Decreasing endoscopists' dynamic ADR was independently associated with metachronous ACRN. A 3.97-, 2.21-, and 2.67-fold increased risk for metachronous ACRN was observed in individuals of which baseline colonoscopy was performed by an endoscopist with a dynamic ADR of < 15%, 15-19%, and 20-24%, respectively, compared with those with the highest dynamic ADR (≥ 25%). The cumulative incidence of metachronous ACRN reached the 5% threshold at 4.5 years, 7.3 years, and 6.2 years in the dynamic ADR < 15%, 15-19%, and 20-24% group, respectively.
Endoscopists' dynamic ADR influences the risk of metachronous ACRN after removal of low-risk findings in screening colonoscopy. Individuals undergoing removal of low-risk findings in screening colonoscopy by an endoscopist with a dynamic ADR < 25% may benefit from a shorter duration of follow-up interval.
内镜医师的腺瘤检出率(ADR)可能随时间变化,动态ADR已被确定为筛查后结直肠癌的预测指标。然而,动态ADR较低的内镜医师切除的低风险病变是否能从较短的随访时间中获益,仍需进一步研究。
我们对切除低风险病变并随后接受结肠镜监测的个体进行了一项双中心回顾性研究。内镜医师的动态ADR是指同一内镜医师之前进行的100次筛查结肠镜检查的ADR。采用Cox回归模型和Kaplan-Meier生存分析来探讨动态ADR与异时性晚期结直肠肿瘤(ACRN)之间的关系。
共有3471例在基线结肠镜检查中切除低风险病变的个体纳入分析。内镜医师动态ADR降低与异时性ACRN独立相关。与动态ADR最高(≥25%)的个体相比,基线结肠镜检查由动态ADR<15%、15-19%和20-24%的内镜医师进行的个体,异时性ACRN风险分别增加3.97倍、2.21倍和2.67倍。动态ADR<15%、15-19%和20-24%组的异时性ACRN累积发病率分别在4.5年、7.3年和6.2年达到5%的阈值。
内镜医师的动态ADR影响筛查结肠镜检查中低风险病变切除后异时性ACRN的风险。在筛查结肠镜检查中由动态ADR<25%的内镜医师切除低风险病变的个体,可能从较短的随访间隔中获益。